francois/HowBadIsMyBatch
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity

updating data for batch codes

Browse Source
This commit is contained in:
no name
2024-09-13 16:19:27 +00:00
parent 07f29e275c
commit 1338bc1ff5
9419 changed files with 6705 additions and 9420 deletions
Download Patch File Download Diff File Expand all files Collapse all files

2
docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/418.json
View File

@@ -1 +1 @@
{"ankylosing spondylitis": 22.02, "condition aggravated": 2.74, "drug hypersensitivity": 2.75, "drug ineffective": 5.57, "drug intolerance": 5.81, "gastric haemorrhage": 18.81, "gastrointestinal disorder": 2.95, "hepatic enzyme increased": 2.62, "inflammation": 6.62, "infusion related reaction": 5.98, "joint swelling": 5.58, "mobility decreased": 3.95, "mouth ulceration": 8.14, "musculoskeletal stiffness": 3.9, "product use in unapproved indication": 2.53, "psoriasis": 3.7, "psoriatic arthropathy": 12.17, "rheumatoid arthritis": 8.11, "therapeutic product effect incomplete": 3.62, "treatment failure": 8.37, "urinary tract infection": 3.02}
{"acute kidney injury": 2.45, "angioedema": 2.15, "ascites": 4.2, "blood creatinine increased": 2.67, "breast cancer": 8.5, "breast cancer metastatic": 48.41, "cytomegalovirus infection": 15.19, "dehydration": 2.63, "disease progression": 4.62, "drug interaction": 6.22, "drug intolerance": 4.67, "drug level increased": 8.97, "drug resistance": 5.34, "general physical health deterioration": 3.0, "hypothyroidism": 2.47, "immunosuppressant drug level increased": 41.08, "interstitial lung disease": 3.01, "leukopenia": 3.9, "lung disorder": 2.55, "lung infiltration": 12.17, "malignant neoplasm progression": 19.73, "metastases to bone": 32.49, "metastases to liver": 51.78, "metastases to lung": 38.19, "metastases to lymph nodes": 25.45, "metastatic renal cell carcinoma": 15.33, "mouth ulceration": 5.47, "mucosal inflammation": 8.73, "neoplasm progression": 6.25, "neuroendocrine tumour": 69.33, "palmar-plantar erythrodysaesthesia syndrome": 4.26, "pancreatic neuroendocrine tumour": 124.43, "pik3ca-activated mutation": 246.19, "pleural effusion": 3.31, "pneumonitis": 14.21, "product use in unapproved indication": 5.44, "renal cell carcinoma": 17.55, "renal impairment": 2.6, "respiratory failure": 3.07, "stomatitis": 7.27, "thrombocytopenia": 2.38, "toxicity to various agents": 5.19, "treatment failure": 2.29}